Case Report: Single-cell Transcriptome Sequencing Reveals the Clonal Origin of Mature Plasmacytoid Dendritic Cell Proliferation in Early T-cell Precursor Lymphoblastic Leukemia

Overview

Journal Ann Hematol

Specialty Hematology

Date 2025 Mar 14

PMID 40085211

Authors

Longyi Zhang

Yan Lu

Jinwen Jiang

Gongqiang Wu

Affiliations

Soon will be listed here.

Abstract

Introduction: Mature plasmacytoid dendritic cell proliferation (MPDCP) is generally considered to be associated with myeloid neoplasms. To date, case reports of MPDCP associated with lymphoid malignancies are exceedingly rare.

Case Report: Herein, we report the case of a 69-year-old male who presented with multiple enlarged preauricular, cervical, inguinal, and axillary lymph nodes. A comprehensive analysis, including morphology, immunophenotyping, and histopathology, confirmed a diagnosis of early T-cell precursor acute lymphoblastic leukemia with MPDCP. Single-cell RNA sequencing identified a transcriptional continuum between T-ALL blasts and pDCs, indicating a potential developmental relationship between these cell types. During the 9-month follow-up period, the patient survived and achieved complete remission.

Conclusion: This case highlights the presence of MPDCP in lymphoid malignancies and utilizes single-cell RNA sequencing technology to provide insights into the potential link between pDC and lymphocyte differentiation and development. However, further studies are needed to confirm these findings and explore their clinical implications.

References

Reizis B . Plasmacytoid Dendritic Cells: Development, Regulation, and Function. Immunity. 2019; 50(1):37-50. PMC: 6342491. DOI: 10.1016/j.immuni.2018.12.027. View

Swiecki M, Colonna M . The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol. 2015; 15(8):471-85. PMC: 4808588. DOI: 10.1038/nri3865. View

Giovanelli P, Sandoval T, Cubillos-Ruiz J . Dendritic Cell Metabolism and Function in Tumors. Trends Immunol. 2019; 40(8):699-718. DOI: 10.1016/j.it.2019.06.004. View

Khoury J, Solary E, Abla O, Akkari Y, Alaggio R, Apperley J . The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022; 36(7):1703-1719. PMC: 9252913. DOI: 10.1038/s41375-022-01613-1. View

Jain A, Sweet K . Blastic Plasmacytoid Dendritic Cell Neoplasm. J Natl Compr Canc Netw. 2023; 21(5):515-521. DOI: 10.6004/jnccn.2023.7026. View

Lucas N, Duchmann M, Rameau P, Noel F, Michea P, Saada V . Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia. Leukemia. 2019; 33(10):2466-2480. DOI: 10.1038/s41375-019-0447-3. View

Zalmai L, Viailly P, Biichle S, Cheok M, Soret L, Angelot-Delettre F . Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape. Haematologica. 2020; 106(12):3056-3066. PMC: 8634182. DOI: 10.3324/haematol.2020.253740. View

Trottier A, Druhan L, Kraft I, Lance A, Feurstein S, Helgeson M . Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies. Blood Adv. 2020; 4(20):5269-5284. PMC: 7594406. DOI: 10.1182/bloodadvances.2020002013. View

Bond J, Touzart A, Lepretre S, Graux C, Bargetzi M, Lhermitte L . mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia. Haematologica. 2019; 104(8):1617-1625. PMC: 6669163. DOI: 10.3324/haematol.2018.197848. View

10.

Zhang Y, Wei H, Tang K, Lin D, Zhang C, Mi Y . Mutation analysis of isocitrate dehydrogenase in acute lymphoblastic leukemia. Genet Test Mol Biomarkers. 2012; 16(8):991-5. PMC: 3422558. DOI: 10.1089/gtmb.2011.0323. View

11.

Aries I, van den Dungen R, Koudijs M, Cuppen E, Voest E, Molenaar J . Towards personalized therapy in pediatric acute lymphoblastic leukemia: RAS mutations and prednisolone resistance. Haematologica. 2014; 100(4):e132-6. PMC: 4380734. DOI: 10.3324/haematol.2014.112995. View

12.

Sakhdari A, Thakral B, Loghavi S, Kanagal-Shamanna R, Yin C, Zuo Z . RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD. Cancer Med. 2019; 9(3):849-858. PMC: 6997098. DOI: 10.1002/cam4.2757. View

13.

Fei F, Liedtke M, Silva O . Case Report: Mature Plasmacytoid Dendritic Cell Proliferation Associated With a Lymphoid Neoplasm. Front Oncol. 2022; 12:903113. PMC: 9296782. DOI: 10.3389/fonc.2022.903113. View

14.

Liao H, Yu J, Liu Y, Zhao S, Zhu H, Xu D . Early T-cell precursor lymphoblastic leukemia accompanied by prominent blastic plasmacytoid dendritic cell proliferation mimicking blastic plasmacytoid dendritic cell neoplasm: an exceptional case report and literature review. J Cancer Res Clin Oncol. 2022; 148(10):2911-2919. DOI: 10.1007/s00432-022-04238-0. View

15.

Xiao W, Chan A, Waarts M, Mishra T, Liu Y, Cai S . Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia. Blood. 2020; 137(10):1377-1391. PMC: 7955409. DOI: 10.1182/blood.2020007897. View

16.

Denker S, Kunstner A, Schwarting J, Witte H, Bernard V, Stolting S . Clonal evolution and blastic plasmacytoid dendritic cell neoplasm: malignancies of divergent hematopoietic lineages emerging from a common founding clone. Leukemia. 2024; 38(8):1858-1861. PMC: 11286505. DOI: 10.1038/s41375-024-02305-8. View

17.

Dress R, Dutertre C, Giladi A, Schlitzer A, Low I, Shadan N . Plasmacytoid dendritic cells develop from Ly6D lymphoid progenitors distinct from the myeloid lineage. Nat Immunol. 2019; 20(7):852-864. DOI: 10.1038/s41590-019-0420-3. View

18.

Belver L, Ferrando A . The genetics and mechanisms of T cell acute lymphoblastic leukaemia. Nat Rev Cancer. 2016; 16(8):494-507. DOI: 10.1038/nrc.2016.63. View

19.

Fahy J, Jeltsch A, Arimondo P . DNA methyltransferase inhibitors in cancer: a chemical and therapeutic patent overview and selected clinical studies. Expert Opin Ther Pat. 2012; 22(12):1427-42. DOI: 10.1517/13543776.2012.729579. View

20.

Rosell R, Aguilar A, Pedraz C, Chaib I . KRAS inhibitors, approved. Nat Cancer. 2022; 2(12):1254-1256. DOI: 10.1038/s43018-021-00289-3. View